CDC's Opioid Stance Hurts Drug Cos. In Marketing Suits

Law360, New York (March 16, 2016, 9:37 PM EDT) -- The U.S. Centers for Disease Control and Prevention's latest push to decrease the prevalence of opioid painkillers primarily targets the prescribing habits of physicians, but opioid manufacturers will also feel its sting when plaintiffs brandish the high-profile agency's guidelines emphasizing the drugs' addictiveness to argue that their marketing was negligent or deceitful, attorneys say. 

The CDC on Tuesday issued a series of voluntary recommendations to discourage physicians from prescribing opioid painkillers, saying physicians should try to exhaust other treatment options before resorting to opioids and should...
To view the full article, register now.